Haleos LABS Limited

Haleos Labs Limited (HALEOSLABS) is a micro-cap Healthcare company valued at ₹464 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Haleos Labs Limited last traded at ₹1,531, modestly down 1.80% on the day.

Recent developments

On 2026-09-18, the company disclosed a material issue related to a USFDA update affecting a subsidiary, which may impact its operations and regulatory compliance.

Financial performance

The company's annual revenue fell 3.2% year-over-year, while net profit declined 6.3%. The latest quarter saw revenue drop 11.6% compared to the same quarter a year earlier, and net profit fell 58.1%.

Valuation multiples

The stock trades at 26.7 times earnings, a discount to the Healthcare median of 32.0, 2.05 times book value. It yields 0.1%.

Things to watch

The company's net profit margin narrowed by 0.2 percentage points to 5.3%. The stock is 16.0% below its 52-week high, and the latest quarter's net profit dropped sharply by 58.1%.

Where it stands

The company's recent financial performance shows declining revenue and profit trends, with the latest quarter reflecting significant declines. The material regulatory issue disclosed on 2026-09-18 adds to the risks facing the business.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.